Prostate cancer: treatment sequencing for CRPC--what do we know?
- PMID: 24595127
- DOI: 10.1038/nrurol.2014.36
Prostate cancer: treatment sequencing for CRPC--what do we know?
Comment on
-
Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents.Eur Urol. 2014 Sep;66(3):459-65. doi: 10.1016/j.eururo.2013.11.044. Epub 2013 Dec 17. Eur Urol. 2014. PMID: 24411987
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
